Skip to main content
. Author manuscript; available in PMC: 2021 Jul 22.
Published in final edited form as: Naunyn Schmiedebergs Arch Pharmacol. 2013 Dec 22;387(4):329–339. doi: 10.1007/s00210-013-0950-4

Fig. 6.

Fig. 6

Fsk-induced IL-6 production with inhibition of PKC (GF 109203X), p38 MAPK (SB 202190) or PI3K (wortmanin). BSMC were pretreated with 10 μM of the indicated inhibitor for 1 h prior to addition of 1 μM Fsk. RNA was isolated after 1 h Fsk treatment and measured by qRT-PCR. Data presented as fold over vehicle, mean ± SEM, n=3